On confounded fishy results regarding arsenic and diabetes

Epidemiology

Volumn 20, Issue 6, 2009, Pages 821-823

  Longnecker, Matthew P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENIC ACID; ARSENIC TRIOXIDE; ARSENOBETAINE; BIOLOGICAL MARKER; CACODYLIC ACID; METHANEARSONIC ACID;

CALCULATION; CONFOUNDING VARIABLE; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; SEA FOOD; URINALYSIS;

ARSENIC; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIABETES MELLITUS, TYPE 2; HUMANS; NUTRITION SURVEYS; SEAFOOD; UNITED STATES;

EID: 74549207427     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181b26bce     Document Type: Note

References (14)

1. Navas-Acien A. Silbergeld EK, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA. 2008;300:814-822.
2. Steinmaus C, Yuan Y, Liaw J, Smith AH. Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus: a re-analysis. Epidemiology. 2009;20:656-664.
3. Navas-Acien A, Silbergeld EK. Pastor-Barriuso R. Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults: updated findings from the National Health Nutrition and Examination Survey. 2003-2006. Epidemiology. 2009;20:668-672.
4. Lai VW, Sun Y, Ting E, Cullen WR, Reimer KJ. Arsenic speciation in human urine: are we all the same? Toxicol Appl Pharm. 2004;198:297306. (Pubitemid 38969959)
5. Fedor D. Kelley DS. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care. 2009;12:138-146.
6. Schulze MB. Hu FB. Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health. 2005;26:445-467.
7. Rami R, Goossler W, Traar P, Ochi T, Francosconi KA. Novel thioarsenic metabolites in human urine after ingestion of an arsenosugar, 2′.3′-dihydroxypropyl 5-deoxy-5-dimethylarsinoyl-beta-D-riboside. Chem Res Toxicol. 2005;18:1444-1450. (Pubitemid 41361718)
8. Francesconi KA. Tanggaar R, McKenzie CJ, Goessler W. Arsenic metabolites in human urine after ingestion of an arsenosugar. Clin Chem. 2002:48:92-101. (Pubitemid 34038127)
9. Devesa V. Súñer MA, Algora S, Vélez D, Montoro R, Jalón M. Urieta I, Macho ML. Organoarsenical species contents in cooked seafood. J Agric Food Chem. 2005;53:8813-8819.
10. Committee on Nutrient Relationships in Seafood: Selections to Balance Benefits and Risks. Malden C. Nesheim and Ann L. Yaktine. eds. Seafood Choices: Balancing Benefits and Risks. Washington, DC: National Academies Press; 2007.
11. Lang IA. Galloway TS. Scarlett A, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA. 2008;300:1303-1310.
12. Everett CJ, Frithsen IL, Diaz VA, Koopman RJ, Simpson WM Jr, Mainous AG III. Association of a polychlorinated dibenzo-p-dioxin, a polychlorinated biphenyl, and DDT with diabetes in the 1999-2002 National Health and Nutrition Examination Survey. Environ Res. 2007:103:413-418.
13. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ. Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 2005;113:192-200.
14. Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Burke TA, Guallar E. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect. 2006;114:641-648.